$500 – $1,000 Paid Clinical Trials
440 studies
Short outpatient Phase 1 studies and multi-visit observational studies often compensate in the $500–$1,000 range.
Compensation amounts shown are typical ranges for this study type — not guaranteed amounts. Actual compensation is set by each study sponsor and documented in the informed consent form. ClinicalTrials.gov does not include a structured compensation field.
Showing 141–160 of 440 studies
Recruiting
Phase 1
A First-in-human Study of the Safety of an Immunosuppressive Antibody (IMP761) in Healthy Volunteers
Healthy
Immutep S.A.S.79 enrolled1 locationNCT06637865
Recruiting
Phase 1
Phase 1 Single Ascending Doses (SAD) of M5542 in Healthy Participants
Healthy
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany49 enrolled1 locationNCT06577337
Recruiting
Phase 1
A Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002)
Healthy
Merck Sharp & Dohme LLC120 enrolled5 locationsNCT07388667
Recruiting
Phase 1
Drug-drug Interaction Trial of AP31969 and Carbamazepine or Itraconazole
Healthy Participants
Acesion Pharma28 enrolled1 locationNCT07449390
Recruiting
Phase 1
Phase I Study of HXN6005 in Adult Healthy Participants
Healthy Volunteers (HV)
Helixon Biotechnology (Suzhou) Co., Ltd32 enrolled1 locationNCT07449741
Recruiting
Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases
healthy adult participantsHealthy ParticipantsHealthy Volunteers+4 more
BeiGene211 enrolled13 locationsNCT06342713
Recruiting
Phase 1
A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions
Healthy
Pfizer24 enrolled1 locationNCT07470866
Recruiting
Phase 1
Safety of Mulberry Leaf Extract Capsule on Blood Glucose Control in Healthy Volunteer
Healthy VolunteersNon Diabetic Hyperglycemia
Chulalongkorn University48 enrolled1 locationNCT07532135
Recruiting
Phase 1
Temporal Interference for Thalamocortical Activity and Network Modulation
Healthy Participants
University of Wisconsin, Madison40 enrolled1 locationNCT07219719
Recruiting
Phase 1
To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy Volunteers
Healthy
JW Pharmaceutical104 enrolled1 locationNCT07514780
Recruiting
Phase 1
A Study to Learn About the Medicine Called PF-08653944 in People With and Without Reduced Liver Function
Healthy
Pfizer26 enrolled3 locationsNCT07519135
Recruiting
Phase 1
A Study to Evaluate the Effect of Food on the Bioavailability of AJ201, and Safety, Tolerability, and Pharmacokinetics of AJ201 in Japanese and White Healthy Male Participants
Food Effect in Healthy VolunteersHealthy Male Adults
AnnJi Pharmaceutical Co., Ltd.26 enrolled1 locationNCT07549919
Recruiting
Phase 1
Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers
Healthy Volunteer
National Institute of Allergy and Infectious Diseases (NIAID)300 enrolled1 locationNCT03878121
Recruiting
Phase 1
A Study of LY4064912 in Healthy Participants and With Overweight or Obesity
HealthyOverweight or Obesity
Eli Lilly and Company144 enrolled3 locationsNCT07152002
Recruiting
Phase 1
A Study to Evaluate Single and Multiple Doses of SEP-479 in Healthy Adult Participants
Healthy Volunteers
Septerna, Inc.150 enrolled1 locationNCT07433179
Recruiting
Phase 1
A Phase I Study Comparing the Relative Bioavailability of a Fixed-Dose Combination of Laroprovstat/Rosuvastatin vs Their Single Therapy Products in Healthy Adults
Healthy Participants
AstraZeneca44 enrolled2 locationsNCT07316608
Recruiting
Phase 1
A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients With C3-Glomerulopathy
healthy adult participantsC3 Glomerulopathy (C3G)
eleva GmbH39 enrolled16 locationsNCT07483827
Recruiting
Phase 1
ENX-205 SAD/PET Study in Healthy Adults
Healthy Volunteer
Engrail Therapeutics INC60 enrolled1 locationNCT07253246
Recruiting
Phase 1
A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer
NeoplasmsHealthy
Eli Lilly and Company41 enrolled6 locationsNCT07258836
Recruiting
Phase 1
Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose
Healthy ParticipantsPharmacokinetics
Amgen400 enrolled5 locationsNCT07422285